BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 19004623)

  • 1. Change of viscoelastic property and morphology of fibrin affected by antithrombin III and heparin: QCM-Z and AFM study.
    Jung H; Tae G; Kim YH; Johannsmann D
    Colloids Surf B Biointerfaces; 2009 Jan; 68(1):111-9. PubMed ID: 19004623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QCM and AFM analysis of anticoagulant activities of sulfonated polymers against fibrin formation.
    Jung H; Kim JY; Kim Y; Tae G; Kim YH; Johannsmann D
    Langmuir; 2009 Jun; 25(12):7032-41. PubMed ID: 19449820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in adsorbed fibrinogen upon conversion to fibrin.
    Evans-Nguyen KM; Fuierer RR; Fitchett BD; Tolles LR; Conboy JC; Schoenfisch MH
    Langmuir; 2006 May; 22(11):5115-21. PubMed ID: 16700602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo.
    Kudrjashov BA; Pastorova VE; Lyapina LA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):731-42. PubMed ID: 6198257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of fibrin clot elasticity.
    Lim BB; Lee EH; Sotomayor M; Schulten K
    Structure; 2008 Mar; 16(3):449-59. PubMed ID: 18294856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QCM-FIA with PGMA coating for dynamic interaction study of heparin and antithrombin III.
    Zhang H; Zhao R; Chen Z; Shangguan DH; Liu G
    Biosens Bioelectron; 2005 Jul; 21(1):121-7. PubMed ID: 15967359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombogenicity of the injured vessel wall--role of antithrombin and heparin.
    Frebelius S; Hedin U; Swedenborg J
    Thromb Haemost; 1994 Jan; 71(1):147-53. PubMed ID: 8165634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ growth of nanogold on quartz crystal microbalance and its application in the interaction between heparin and antithrombin III.
    Zhang Q; Huang Y; Zhao R; Liu G; Chen Y
    J Colloid Interface Sci; 2008 Mar; 319(1):94-9. PubMed ID: 18082175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of thrombin inactivation by immobilized heparin.
    Byun Y; Jacobs HA; Kim SW
    J Biomed Mater Res; 1996 Apr; 30(4):423-7. PubMed ID: 8847350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal fibrin-formation and its inhibition in CAPD.
    Gries E; Paar D; Graben N; Bock KD
    Clin Nephrol; 1986 Oct; 26(4):209-12. PubMed ID: 3780071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin].
    Kudriashov BA; Pastorova VE; Liapina LA
    Biokhimiia; 1981 Nov; 46(11):2024-9. PubMed ID: 7317530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin proliferation at model surfaces: influence of surface properties.
    Evans-Nguyen KM; Schoenfisch MH
    Langmuir; 2005 Mar; 21(5):1691-4. PubMed ID: 15723458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface-adsorbed fibrinogen and fibrin may activate the contact activation system.
    Sanchez J; Elgue G; Larsson R; Nilsson B; Olsson P
    Thromb Res; 2008; 122(2):257-63. PubMed ID: 18177925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of thrombin and plasmin to heparin and antithrombin III.
    Bauer PI; Breuer Z; Machovich R; Büki KG; Horváth I
    Acta Biochim Biophys Acad Sci Hung; 1985; 20(3-4):155-61. PubMed ID: 2944348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled preparation of thin fibrin films immobilized at solid surfaces.
    Riedel T; Brynda E; Dyr JE; Houska M
    J Biomed Mater Res A; 2009 Feb; 88(2):437-47. PubMed ID: 18306296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin-hirudin complex stability: a comparison with the thrombin-antithrombin III complex.
    Römisch J; Pâques EP
    Blood Coagul Fibrinolysis; 1991 Oct; 2(5):643-6. PubMed ID: 1782334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viscoelastic modeling of highly hydrated laminin layers at homogeneous and nanostructured surfaces: quantification of protein layer properties using QCM-D and SPR.
    Malmström J; Agheli H; Kingshott P; Sutherland DS
    Langmuir; 2007 Sep; 23(19):9760-8. PubMed ID: 17691829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of fibrin gel elasticity by enzymes: a kinetic approach.
    Akpalo E; Larreta-Garde V
    Acta Biomater; 2010 Feb; 6(2):396-402. PubMed ID: 19664730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin III: a backward glance o'er travel'd roads.
    Seegers WH
    Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leucocyte migration inhibition factor (LIF) and antithrombin III (AT III).
    Weber TH; Mäkinen T; Welin MG
    J Clin Lab Immunol; 1980 Jul; 4(1):47-8. PubMed ID: 7007650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.